Viedoc
Viedoc Technologies AB, founded 2003 in Uppsala, Sweden, provides a cloud-based modular eClinical SaaS platform — including EDC, ePRO, eTMF, randomization, RTSM, and televisits — serving CROs, pharma and biotech sponsors, medical device firms, and academic institutions across more than 75 countries via study-based subscription pricing.
- Company typePrivate
- Founded2003
- HeadquartersUppsala, Sweden
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Viedoc does
Viedoc Technologies AB is a privately held Swedish eClinical SaaS provider, founded in 2003 by technologists from the CRO community and headquartered in Uppsala. The company sells a modular, cloud-based clinical trial platform whose core modules include Viedoc EDC (Electronic Data Capture), Viedoc ePRO (electronic patient-reported outcomes with the Viedoc Me patient portal), Viedoc Televisits for decentralized trials, Viedoc eTMF (Electronic Trial Master File), Randomization, RTSM (Randomization and Trial Supply Management), Medical Coding, eSignature, and Record Sharing. Recent additions include the Viedoc SDV Manager for risk-based source data verification and DICOM de-identification for medical imaging workflows, all delivered through a browser-based architecture with 99.99% uptime and support for 40+ languages across 75+ countries. The platform is designed for fast deployment, averaging 10 weeks for study build, and targets compliance with 21 CFR Part 11, GDPR, HIPAA, ICH GCP, GAMP 5, CDISC, ISO 27001:2022, SOC 2 Type 2, APPI, and CSA STAR Level 1.
The company serves three primary customer segments — Contract Research Organizations (CROs), pharma and biotech sponsors, and medical device companies — with a secondary base in academic and research institutions. The customer roster spans multiple named CROs (Clinfidence, FGK CRO, LINK Medical, Linical, MDCE CRO, SMERUD, TECRO), pharma sponsors (Dicot Pharma, RHEACELL), medical device firms (Sonex Health, Qmed, Chordate Medical), and academic institutions (University of Oslo). Revenue is generated through a SaaS subscription model with study-based (not per-seat) pricing, modular licensing of features, annual billing, and optional professional services including Certified Designer Training, Study Build, and Customer Success. Distribution is direct enterprise field sales supported by a CRO Partner Directory and wholly-owned sales entities in the US (Raleigh), Japan (Tokyo), China (Shanghai), Vietnam (Hanoi, engineering), and Australia (Melbourne), enabling regional data residency for EU, US, Japan, and China regulatory regimes. The firm is founder-owned, has approximately 140 employees, and has accumulated more than 7,000 studies, 30,000+ sites, and 1.6M+ participants on the platform.
Viedoc firmographics
Firmographics- Name
- Viedoc
- Legal name
- Viedoc Technologies AB
- Website
- https://viedoc.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Viedoc Technologies AB, founded 2003 in Uppsala, Sweden, provides a cloud-based modular eClinical SaaS platform — including EDC, ePRO, eTMF, randomization, RTSM, and televisits — serving CROs, pharma and biotech sponsors, medical device firms, and academic institutions across more than 75 countries via study-based subscription pricing.
- Ownership category
- akta.pro rank
Viedoc industry classification
Industry- Product category
- Clinical Trial Management Software (eClinical Platform)
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Electronic Data Capture (EDC) Platforms (HLACAOAA)
- akta.pro secondary industries
- eTMF & Trial Document Management (HLACAOAF), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
Keywords
Where Viedoc is headquartered
LocationHeadquarters
- HQ city
- Uppsala
- HQ country
- Sweden
- HQ region
- Europe
Offices6 records
Markets served
Viedoc business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Licensing: Viedoc operates on a SaaS subscription model with modular, study-based pricing. Customers pay for their study rather than per user, with unlimited users included at no extra cost. Features are modular, allowing customers to choose EDC, ePRO, Televisits or other modules as needed.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Modular study-based licensing with optional modules |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Viedoc product offering
Product offeringCore offering
Viedoc provides a cloud-based, modular eClinical SaaS platform that enables pharmaceutical, biotech, medical device, and contract research organizations to run clinical trials end-to-end. Core modules include Electronic Data Capture (EDC), electronic Patient-Reported Outcomes (ePRO), Televisits for decentralized trials, Electronic Trial Master File (eTMF), randomization, RTSM (trial supply management), medical coding, eSignature, and record sharing. The platform is licensed on a study-basis (not per user) with annual subscriptions and includes hosting, backups, support, and regulatory compliance for FDA, EMA, and PMDA submissions.
Product overview
Viedoc is a cloud-based eClinical platform providing an integrated suite of clinical trial software solutions. The platform operates on a modular architecture allowing sponsors and CROs to select and combine capabilities including EDC (electronic data capture), ePRO (electronic patient-reported outcomes), Televisits (decentralized trial support), eTMF (trial master file management), Medical Coding, Randomization, RTSM (trial supply management), Record Sharing, and eSignature. Key features include Viedoc SDV Manager for targeted source data verification supporting risk-based quality management, ViedocReports for analytics and exports, and Viedoc Me as a patient-facing portal for remote participation. The platform is designed for rapid deployment with a 10-week study build time average, supports 40+ languages, and maintains compliance with major regulatory frameworks including FDA, EMA, and PMDA.
Differentiator
Problem solved
Functional benefit
Brands
- Viedoc Me: Patient portal application for clinical trial participants
- Viedoc Designer
- Viedoc Clinic
- Viedoc EDC
- Viedoc ePRO
- Viedoc eTMF
- ViedocReports
- Viedoc API
Products and services
- Viedoc EDC (Electronic Data Capture) Browser-based platform for collecting, validating, verifying, and monitoring high-quality clinical trial data in real time, with audit trails and configurable workflows. Designed for sponsors and CROs running clinical studies.
- Viedoc ePRO (Electronic Patient-Reported Outcomes) Patient-facing module enabling direct reporting of outcomes into the platform, eliminating manual data entry delays. Includes the Viedoc Me patient portal for remote participation.
- Viedoc Televisits Remote visit capability that brings decentralized participation into trial workflows, enabling clinical observations and patient data capture from any location.
- Viedoc eTMF (Electronic Trial Master File) Document management system for maintaining trial master file documentation, ensuring organized storage and retrieval of trial documents throughout the study lifecycle.
- Viedoc Medical Coding Automated medical coding tool supporting MedDRA and WHO Drug dictionary integration for coding adverse events and medications consistently across studies.
- Viedoc Randomization Clinical trial randomization software managing subject allocation to treatment arms with configurable randomization configurations.
- Viedoc RTSM (Randomization and Trial Supply Management) Trial supply management software for managing drug kit allocation, supply logistics, and inventory across investigator sites.
- Viedoc Record Sharing Capability enabling secure sharing of clinical records and data across authorized parties within the trial ecosystem.
- Viedoc eSignature Electronic signature capability enabling compliant digital signing of documents and forms within the platform, supporting 21 CFR Part 11 compliance.
- Viedoc PMS (Post-Market Surveillance, Japan) Post-market surveillance software designed specifically for the Japanese market, supporting Japan PMDA regulatory requirements for medical devices and pharmaceuticals.
- Viedoc API Public application programming interface that enables integrations with third-party systems, with accompanying Tech Partnership Directory and Connector Service.
Quantifiable outcome
- 98% study-visit compliance achieved by Sonex Health using Viedoc ePRO
- +6 more outcomes
Companies that use Viedoc
Customer profileNamed customers13 records
Segments4 records
Ideal customer profiles4 records
Viedoc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Viedoc partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- TrialtcoreStrategic collaboration announced April 3, 2026 between Trialt (global CRO specializing in biostatistics and data management) and Viedoc. Partnership combines Viedoc's technology platform with Trialt's biometrics expertise to help sponsors accelerate clinical trial timelines, strengthen data quality, and improve decision-making. Supports global and decentralized trials with goal of connected experience from data capture through analysis.
- StudioncoreStrategic partnership announced December 15, 2025 to enhance eClinical services for clinical trials. Collaboration combines Viedoc's platform with Studion's expertise to improve study quality, speed, and data integrity. Partnership aims to support sponsors and CROs in executing faster, more reliable clinical research.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Viedoc competitors and assessment
Company assessmentEmerging players
- Medable: Medable is a leading decentralized clinical trial platform offering eCOA, eConsent, telehealth, and remote monitoring. It overlaps with Viedoc's Televisits, ePRO, and DCT modules and is a credible competitor for DCT-focused RFPs.
- Science 37: Science 37 operates a decentralized clinical trial operating system with integrated telemedicine, eCOA, and connected devices. It competes with Viedoc's DCT and Televisits capabilities, particularly for fully decentralized sponsor studies.
Direct peers
- Signant Health: Signant Health (combining CRF Health and Bracket) provides eCOA, EDC, patient engagement, and rater training for clinical trials. It directly competes with Viedoc in ePRO, EDC, and decentralized trial enablement.
- Medrio: Medrio provides cloud-based EDC, ePRO, eConsent, and RTSM solutions for clinical trials, especially for early-phase and post-market studies. It competes with Viedoc for mid-market and academic customers.
- OpenClinica: OpenClinica offers EDC, ePRO, and clinical data management software for academic and commercial trials. It is a comparable mid-sized cloud EDC vendor competing in similar customer segments.
- Castor EDC: Castor is a cloud-native EDC and ePRO platform targeting academic, CRO, and small/mid-pharma sponsors with modular pricing. It overlaps directly with Viedoc in EDC, ePRO, and decentralized trial functionality.
Broad incumbents
- Clario: Clario (formed from ERT and Bioclinica) provides eCOA, EDC, cardiac safety, medical imaging, and trial endpoint solutions to pharma sponsors. It competes with Viedoc across ePRO, EDC, and imaging-adjacent workflows including DICOM handling.
- Veeva Systems: Veeva's Vault Clinical Suite includes Vault EDC, Vault CTMS, Vault CDB, and ePRO capabilities targeting large pharma sponsors. Its broad life-sciences CRM and content footprint make it a direct competitor for enterprise clinical platform deals.
- Oracle Clinical One: Oracle's Clinical One platform unifies EDC, RTSM, ePRO, and trial design under one cloud platform. As a large enterprise software vendor, it competes head-to-head with Viedoc in mid-to-large pharma trials.
- Medidata (Dassault Systèmes): Medidata offers the industry-leading Rave EDC platform plus a broad clinical cloud suite (CTMS, eCOA, RTSM, imaging, analytics). It is the dominant incumbent against which Viedoc competes for sponsor and CRO EDC RFPs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Viedoc social profiles
Digital presenceViedoc compliance and trust
Trust signalCompliance11 records
Viedoc financial estimates
Financial estimateRevenue estimate
Valuation estimate
Viedoc leadership team
Management profileNumber of profiles
Profiles7 records
Viedoc subsidiaries and ownership
Company hierarchySubsidiaries4 records
Viedoc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Viedoc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Viedoc
What does Viedoc do?
Viedoc provides a cloud-based, modular eClinical SaaS platform that enables pharmaceutical, biotech, medical device, and contract research organizations to run clinical trials end-to-end. Core modules include Electronic Data Capture (EDC), electronic Patient-Reported Outcomes (ePRO), Televisits for decentralized trials, Electronic Trial Master File (eTMF), randomization, RTSM (trial supply management), medical coding, eSignature, and record sharing. The platform is licensed on a study-basis (not per user) with annual subscriptions and includes hosting, backups, support, and regulatory compliance for FDA, EMA, and PMDA submissions.
Is Viedoc a public or private company?
Viedoc is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Viedoc founded?
Viedoc was founded in 2003. It employs 101 to 250 people.
Where is Viedoc based?
Viedoc is headquartered in Uppsala, Sweden, in the Europe region.
How does Viedoc make money?
One revenue line is on record: saaS Platform Licensing.
Who are Viedoc's main competitors?
Emerging players on record are Medable and Science 37. Direct peers are Signant Health, Medrio, OpenClinica and Castor EDC. Broad incumbents are Clario, Veeva Systems, Oracle Clinical One and Medidata (Dassault Systèmes).
Does Viedoc have an API?
Yes. Viedoc offers a public API that enables integrations with third-party systems. The platform includes a Tech Partnership Directory for discovering integrations and a Connector Service for linking external tools. Developer documentation is at www.viedoc.com/viedoc-api.
What industry is Viedoc in?
Viedoc's product category is Clinical Trial Management Software (eClinical Platform). Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms, with a secondary code of HLACAOAF, eTMF & Trial Document Management. Its NAICS code is 5132 and its SIC code is 7372.